Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eddy Demarsin"'
Publikováno v:
Blood. 96:1425-1432
Site directed mutagenesis (350 variants) of recombinant staphylokinase (SakSTAR), a potent fibrin-selective thrombolytic agent, was undertaken in order to reduce its antigenicity while maintaining its potency. Variants with K35A, (ie, Lys[K] in posit
Autor:
J. P. Roodt, Muriel Meiring, Philippe Barbeaux, Eddy Demarsin, Alexandre Fontayne, Seb Lamprecht, Hans Deckmyn
Publikováno v:
Thrombosis and haemostasis. 100(4)
SummaryThe Fab-fragment of 6B4, a murine monoclonal antibody targeting the human platelet glycoprotein (GP) Ibα and blocking the binding of von Willebrand factor (VWF), is a powerful antithrombotic. In baboons, this was without side effects such as
Autor:
Marc De Maeyer, Eddy Demarsin, H Moreau, Yves Laroche, Desire Collen, Frans Van de Werf, Laurent Jespers, Peter Sinnaeve
Publikováno v:
Circulation. 102(15)
Background —Thrombolytic therapy of acute myocardial infarction (AMI) is evolving toward bolus administration. Derivatization of proteins with polyethylene glycol (PEG) may reduce their clearance. Methods and Results —A staphylokinase (SakSTAR) v
Publikováno v:
Blood. 69:592-596
The specific thrombolytic properties of urokinase and three molecular forms of single-chain urokinase-type plasminogen activator (scu-PA) were compared in a human plasma milieu in vitro and in an experimental thrombosis model in rabbits. These scu-PA